 CytoSorbents Corporation NASDAQ: CTSO receives full FDA approval to conduct the STAR-T trial in the U.S. to support regulatory clearance of DrugSorb Antithrombotic Removal ATR system for intraoperative ticagrelor removal during cardiothoracic surgery. This study is being performed under the previously announced FDA Breakthrough Designation received in April 2020. 